These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36602623)

  • 1. Usefulness of serum neurofilament light in the assessment of neurologic outcome in the pediatric population: a systematic literature review.
    Jacobs Sariyar A; van Pesch V; Nassogne MC; Moniotte S; Momeni M
    Eur J Pediatr; 2023 May; 182(5):1941-1948. PubMed ID: 36602623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infants.
    Goeral K; Hauck A; Atkinson A; Wagner MB; Pimpel B; Fuiko R; Klebermass-Schrehof K; Leppert D; Kuhle J; Berger A; Olischar M; Wellmann S
    J Neurol; 2021 Jul; 268(7):2570-2577. PubMed ID: 33566157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
    Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
    Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases.
    Geis T; Gutzeit S; Fouzas S; Ambrosch A; Benkert P; Kuhle J; Wellmann S
    Eur J Paediatr Neurol; 2023 Jul; 45():9-13. PubMed ID: 37236127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome.
    Butt OH; Zhou AY; Caimi PF; Luckett PH; Wisch JK; Derenoncourt PR; Lee K; Wu GF; de Lima MJG; Campian JL; Frank MJ; DiPersio JF; Ghobadi A; Ances BM
    JAMA Oncol; 2022 Nov; 8(11):1652-1657. PubMed ID: 36048456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population-an analysis from the MEMO study.
    Rübsamen N; Maceski A; Leppert D; Benkert P; Kuhle J; Wiendl H; Peters A; Karch A; Berger K
    BMC Med; 2021 Feb; 19(1):38. PubMed ID: 33583409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neurological biomarkers as a measure of neurotoxicity in pediatric dental general anesthesia: a prospective observational feasibility study.
    Chakithandy S; Nazzal H; Matoug-Elwerfelli M; Narasimhan S; Uddin S; Prabhu KS; Zarif L; Mumtaz N; Sharma A; Al-Khelaifi M
    Eur Arch Paediatr Dent; 2024 Apr; 25(2):267-275. PubMed ID: 38649631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) cohort.
    Stukas S; Cooper J; Higgins V; Holmes D; Adeli K; Wellington CL
    Clin Chem Lab Med; 2024 Mar; 62(4):698-705. PubMed ID: 37882772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury.
    Wentz E; Dobrescu SR; Dinkler L; Gillberg C; Gillberg C; Blennow K; Råstam M; Zetterberg H
    Eur Child Adolesc Psychiatry; 2021 Dec; 30(12):1907-1915. PubMed ID: 33040187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia.
    Donath H; Woelke S; Schubert R; Kieslich M; Theis M; Auburger G; Duecker RP; Zielen S
    Cerebellum; 2022 Feb; 21(1):39-47. PubMed ID: 33893614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament light chain as a predictive marker of neurologic outcome after cardiac arrest: a meta-analysis.
    Wang SL; Li N; Feng SY; Li Y
    BMC Cardiovasc Disord; 2023 Apr; 23(1):193. PubMed ID: 37061702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light chain in patients with a concussion or head impacts: a systematic review and meta-analysis.
    Karantali E; Kazis D; McKenna J; Chatzikonstantinou S; Petridis F; Mavroudis I
    Eur J Trauma Emerg Surg; 2022 Jun; 48(3):1555-1567. PubMed ID: 34003313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.
    Veenhuis SJG; Gupta AS; de Gusmão CM; Thornton J; Margus B; Rothblum-Oviatt C; Otto M; Halbgebauer S; van Os NJH; van de Warrenburg BPC; Verbeek MM; Willemsen MAAP
    Eur J Paediatr Neurol; 2021 May; 32():93-97. PubMed ID: 33878608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants.
    Sjöbom U; Hellström W; Löfqvist C; Nilsson AK; Holmström G; Pupp IH; Ley D; Blennow K; Zetterberg H; Sävman K; Hellström A
    JAMA Netw Open; 2021 Apr; 4(4):e214138. PubMed ID: 33797551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined GFAP, NFL, Tau, and UCH-L1 panel increases prediction of outcomes in neonatal encephalopathy.
    Yang Z; Xu H; Sura L; Arja RD; Patterson RL; Rossignol C; Albayram M; Rajderkar D; Ghosh S; Wang K; Weiss MD
    Pediatr Res; 2023 Apr; 93(5):1199-1207. PubMed ID: 35273370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprognostication value of serum neurofilament light chain for out-of-hospital cardiac arrest: A systematic review and meta-analysis.
    Fu Y; Fan XT; Li H; Zhang R; Zhang DD; Jiang H; Chen ZG; Zhang JT
    PLoS One; 2023; 18(9):e0290619. PubMed ID: 37713399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.
    Kammeyer R; Mizenko C; Sillau S; Richie A; Owens G; Nair KV; Alvarez E; Vollmer TL; Bennett JL; Piquet AL
    Front Neurol; 2022; 13():689975. PubMed ID: 35309573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges.
    Bayoumy S; Verberk IMW; Vermunt L; Willemse E; den Dulk B; van der Ploeg AT; Pajkrt D; Nitz E; van den Hout JMP; van der Post J; Wolf NI; Beerepoot S; Groen EJN; Tüngler V; Teunissen CE
    Clin Chem Lab Med; 2024 Jun; 62(7):1252-1265. PubMed ID: 38215341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.